US 2023/0416244 A1Published application

Imidazoquinoline compound having anti-inflammatory, antifugal, antiparasitic, and anticancer activity

AssigneeWellstat Therapeutics Corporation

InventorsDAVID MICHAEL SIMPSON, Reid Warren VON BORSTEL, Rolando Alejandro GARCIA GARCIA

Life of this patent

Estimating the term…

An imidazoquinoline compound having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer is described.

Dependent claims

A compound selected from the group consisting of:

2-(3-Phenoxybenzyl)-1H-imidazo[4,5-c]quinoline and pharmaceutically acceptable salts thereof.

Dependencies are inferred from the claim text.

A61K 39/39
Medicinal preparations containing antigens or antibodies: characterised by the immunostimulating additives, e.g. chemical adjuvants
C07D 471/04
In which the condensed system contains two hetero rings: ortho-condensed systems
A61K 31/4706
Quinolines; Isoquinolines: 4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
A61K 31/4745
Ortho- or peri-condensed with heterocyclic ring systems: condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines

From the US filing history. Foreign family members aren’t listed.

Loading patent…